7-[3,3-dimethyl-2-(trifluoromethyl)cyclobutanecarbonyl]-3,5,6,8-tetrahydropyrido[3,4-d]pyrimidin-4-one
C15H18F3N3O2 — CID 155955810
Data last refreshed: (MolForge compound catalog, from PubChem)
About 7-[3,3-dimethyl-2-(trifluoromethyl)cyclobutanecarbonyl]-3,5,6,8-tetrahydropyrido[3,4-d]pyrimidin-4-one
7-[3,3-dimethyl-2-(trifluoromethyl)cyclobutanecarbonyl]-3,5,6,8-tetrahydropyrido[3,4-d]pyrimidin-4-one (PubChem CID 155955810) has the molecular formula C15H18F3N3O2 and a molecular weight of 329.32 g/mol. Its IUPAC name is 7-[3,3-dimethyl-2-(trifluoromethyl)cyclobutanecarbonyl]-3,5,6,8-tetrahydropyrido[3,4-d]pyrimidin-4-one.
Molecular Properties
| Compound Name | 7-[3,3-dimethyl-2-(trifluoromethyl)cyclobutanecarbonyl]-3,5,6,8-tetrahydropyrido[3,4-d]pyrimidin-4-one |
|---|---|
| PubChem CID | 155955810 |
| Molecular Formula | C15H18F3N3O2 |
| Molecular Weight | 329.32 g/mol |
| Exact Mass | 329.14 |
| IUPAC Name | 7-[3,3-dimethyl-2-(trifluoromethyl)cyclobutanecarbonyl]-3,5,6,8-tetrahydropyrido[3,4-d]pyrimidin-4-one |
| SMILES | CC1(C)CC(C(=O)N2CCc3c(nc[nH]c3=O)C2)C1C(F)(F)F |
| InChI | InChI=1S/C15H18F3N3O2/c1-14(2)5-9(11(14)15(16,17)18)13(23)21-4-3-8-10(6-21)19-7-20-12(8)22/h7,9,11H,3-6H2,1-2H3,(H,19,20,22) |
| InChIKey | FZVFJGBLOJSJER-UHFFFAOYSA-N |
| XLogP | 1.88 |
| TPSA | 66.06 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 1 |
| Heavy Atoms | 23 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 329.32 |
| LogP ≤ 5 | 1.88 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155955810 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.